🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The incomparable @PamSharmaMDPhD, Allison Institute Director of Scientific Operations, rocks the mic at keystone advising young investors to be BOLD and bring new effective anti-tumors therapeutics into the clinic to CURE our patients

Amazing talk!!!

Congratulations to @PamSharmaMDPhD on being named a Fellow of the AACR Academy. “Dr. Sharma strives to advance impactful immunotherapy research, leading numerous trials and research studies that have informed our current understanding of cancer and improved the lives of

Epitome of a true #PhysicianScientist: Brilliant scientist, caring physician, translating new therapies, #clinicaltrials and impacting generations of scientists through her #mentoring and #sponsoring. The world is better because you are in it @PamSharmaMDPhD. Congratulations!

Fascinating talk by Nima Sharifi at Chris Wood Symposium on the impact of differential androgen metabolism in men with prostate cancer

Excited to publish Harvard Data Science Review an overview on interpreting randomized controlled trials focusing on information. By prioritizing this fundamental principle, previously obscure statistical concepts reveal their intrinsic beauty: hdsr.mitpress.mit.edu/pub/yb9eq8ja/r…

1/4 Congrats to Ana Aparicio and team on this adaptive, investigator-initiated trial of 192 men with mCRPC Clinical Cancer Research ! shorturl.at/uwAFS  All men got 8 weeks of AAPA. Based on PSA decline at 8 weeks, went on to add ipi, continue AAPA, or add cabazi/carbo

Excellent Allison Institute seminar this week from Samir Zaidi, MD, PhD . Looking forward to hearing more about cancer cell plasticity.

Cheers! At Harry Cipriani’s with bellinis to start the celebrations for Robert & Lauren’s wedding on Saturday!! ⁦Ana Aparicio⁩ ⁦@PamSharmaMDPhD⁩ ⁦Diana Rafanan⁩

1/4 Published in Cancer Immunology Research! Evaluation of cardiac & skeletal muscle biopsies in patients w/myocarditis & myositis identified immune mechanisms possibly contributing to these fatal irAEs. MD Anderson Cancer Center @PamSharmaMDPhD Sumit Subudhi Nicolas Palaskas, MD Linghua Wang, MD, PhD aacrjournals.org/cancerimmunolr…

If you missed the oral prostate session yesterday or want to hear my thoughts about it, come check out our Highlights of Prostate session at 900 AM in hall D1 MD Anderson Cancer Center #ASCO24

Check out our editorial on CV risk in men with prostate cancer treated with ADT shorturl.at/ZsZEo Prostate Cancer and Prostatic Diseases We discuss the need to develop risk models specific to men with PCa and to better understand the biologic determinants of toxicity Ana Aparicio MD Anderson Cancer Center

Very thought provoking! Ravi A Madan M.D. Rick Lee 이재방 Edwin Posadas, MD Fatima Yaftali Karzai, M.D. Restaging With PSMA Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Hot off the presses! NCI CCR GU Malignancies @NCIResearchCtr great work Ravi A Madan M.D.

The S2312 trial in #mCRPC asks if adding carboplatin to cabazitaxel will significantly improve radiographic PFS in patients whose tumors are aggressive variant #prostatecancer (AVPC-MS) vs those whose tumors are not. PI: Paul Corn, MD, PhD MD Anderson Cancer Center swog.org/clinical-trial…

The S2312 trial in #mCRPC asks if adding carboplatin to cabazitaxel will significantly improve radiographic PFS in patients whose tumors are aggressive variant #prostatecancer (AVPC-MS) vs those whose tumors are not. PI: Paul Corn, MD, PhD MD Anderson Cancer Center swog.org/clinical-trial…

Hear Ye! Hear Ye! The AACR Annual Election is here! Vote for the man, the myth for AACR Board of Directors!

Great case discussions from our GU team reviewing adjuvant pembro this morning. And remembering Chris Wood. ⁦MD Anderson Cancer Center⁩

This moment feels surreal. The funding of cancer research must continue. Cancer is not partisan. Ask for ongoing CDMRP support! ASCO Kidney Cancer KCCure The PCCTC Prostate Cancer Foundation